A naturally truncated NS1 protein of influenza A virus impairs its interferon-antagonizing activity and thereby confers attenuation in vitro.

This study examines the role of a naturally truncated non-structural protein of the influenza A virus (NS1A protein) in the virus’s life cycle and its effect on its host’s immune responses. The researchers discovered that this truncated NS1A protein weakens the virus’s ability to counteract antiviral defenses, which in turn reduces virus replication.

Research Purpose and Scope

• The main purpose of the research was to study the role of a naturally truncated NS1A protein in the life cycle of the Influenza A virus, in contrast to its full-length variant, and its effects on host immune responses.
• The researchers focused on a particular influenza virus variant, H3N8 A/Equine/Kyonggi/SA1/2011 (KG11), which was isolated from horses in Korea showing respiratory disease symptoms. This KG11 virus contained a truncated NS gene segment, which resulted in the truncation of the effector domain of the NS1A protein.

Research Methods and Observations

• The research introduced KG11 virus into cells and observed an attenuated growth cycle and a smaller plaque size when compared to the A/Equine/Miami/1/1963 H3N8 (MA63) virus, which carries a full-length NS1A protein.
• To understand this attenuation, the activation levels of Akt (a protein kinase responsible for cell proliferation and survival) and interferon regulatory factor 3 (IRF-3, involved in the regulation of interferon in response to viral infection) pathways were evaluated.
• The study observed that the activation of Akt was reduced, while phosphorylation of IRF-3 increased in KG11-infected cells compared to those infected with the MA63 virus.
• Analysis of downstream gene induction showed a significant increase in expression of antiviral and pro-inflammatory genes in the case of KG11 virus infection.

Research Conclusions

• The study’s findings suggest that the naturally truncated NS1A protein present in the KG11 virus hinders the virus’s ability to inhibit host antiviral responses.
• The result of this impaired ability to counteract antiviral defenses is a reduction in the virus’s replication efficiency, referred to as attenuation.
• Therefore, the study highlights the impact of the naturally truncated NS1A protein on the influenza A virus’s life cycle and its potential applications in further antiviral studies or vaccine development.